Skip to content
lifestyle.imone2015.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Olema Oncology
Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting
May 21, 2026
Olema Oncology to Participate in Upcoming Investor Conferences
May 19, 2026
Olema Oncology Reports First Quarter 2026 Financial and Operating Results
May 12, 2026
Olema Oncology to Participate in Upcoming Investor Conferences
February 19, 2026
←
Previous Page
1
2